CHOLESTEROL SYNTHESIS INHIBITORS IN HYPERLIPIDAEMIA
- 1 March 1988
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 331 (8585) , 597
- https://doi.org/10.1016/s0140-6736(88)91401-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemiaAtherosclerosis, 1988
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemiaMetabolism, 1987
- EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1986
- Preliminary report: Treatment of type 3 hyperlipoproteinemia with mevinolinMetabolism, 1986
- Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglyceridesMetabolism, 1982